Wednesday, 6 March 2019

Allergan's add-on treatment for depression fails late-stage studies

Allergan Plc said on Wednesday its experimental add-on treatment for major depressive disorder failed to meet the main goals of three late-stage studies.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)